Edgewise Therapeutics Reports Q2 2026 Financial Results

What Happened

• On August 6, 2026, Edgewise Therapeutics, Inc. (EWTX) announced its financial results for the quarter ended June 30, 2026 by issuing a press release. The press release is attached to the Form 8-K as Exhibit 99.1 and is referenced under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 6, 2026 (Form 8-K, Item 2.02).
• Reporting period: quarter ended June 30, 2026.
• Press release attached as Exhibit 99.1 and incorporated by reference into the 8-K.
• The filing states the exhibit is “furnished” (Item 9.01) and is not deemed “filed” for purposes of Section 18 of the Exchange Act, nor automatically incorporated by reference into other SEC filings except by specific reference.

Why It Matters

• This 8-K signals that Edgewise has released its quarterly earnings and related operational updates; investors should read the attached press release (Exhibit 99.1) for revenue, expense, cash position, and program updates.
• The legal note that the exhibit is “furnished” (not “filed”) affects the technical SEC liability and incorporation status—investors seeking statements to rely on should watch for those figures and disclosures in later filed reports (e.g., the next 10-Q) or specific filings that incorporate the release by reference.